Skip to main content

Table 1 Patient characteristics

From: Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy

 

CIDP all

Typical CIDP

Atypical CIDP

HC

N total

33

16

17

28

sex, female (%)

12 (36,4)

10 (62,5)

2 (11,76)

P = 0.004

14 (50)

age (years), mean (SD)

64,18 (9,94)

62,50 (11,65)

65,75 (8,04)

59,54 (8,94)

median (range)

65 (44–82)

61 (44–82)

68 (52–80)

60 (37–77)

time since diagnosis, years, median (IQR)

5 (2–8)

7,5 (2.75–14.25)

3 (2–7)

n.a.

CIDP disease activity status –stabile (%)

26 (85.8)

14 (87.5)

12 (70.6)

n.a.

handedness, right handed (%)

31/32a (96.8)

16 (100)

16 (94)

n.a.

INCAT ODSS, mean (SD)

3.4 (1.6)

4.4 (1.5)

2.4 (1.0)

P = 0.0002

n.a.

- arms

1.4 (0.75)

2.4 (1.0)

1.4 (0,96)

P = 0.003

n.a.

- legs

1.5 (0.9)

2 (1.0)

1.0 (0.001)

n.a.

MRC, mean (SD)

71.5 (7.5)

68.9 (9.9)

73.0 (5.1)

n.a.

treatment actually/ever (%)

- glucosteroids

7/24 (21/72.8)

5/13 (31/81)

2/11 (12/64)

n.a.

- IVIg

19/33 (58/100)

10/16 (63/100)

9/17 (53/100)

n.a.

- PE

0/8 (0/24.2)

0/4 (0/25)

0/4 (0/23)

n.a.

- other

5/7 (15/21)

3/5 (19/31)

2/2 (12/12)

n.a.

  1. a missing data of one patient regarding handedness in CIDP group
  2. Abbreviations: INCAT Inflammatory Neuropathy Cause and Treatment disability score, MRC Medical Research Counsil, SD Standard deviation, IQR Interquartile range, IVIg Intravenous immunoglobulin, PE Plasma exchange